首页> 外国专利> RECEPTOR SPECIFIC CHIMERIC VIRAL SURFACE POLYPEPTIDES FOR VIRAL AND PARTICLE INCORPORATION AND INTERNALIZATION IN TARGET CELLS

RECEPTOR SPECIFIC CHIMERIC VIRAL SURFACE POLYPEPTIDES FOR VIRAL AND PARTICLE INCORPORATION AND INTERNALIZATION IN TARGET CELLS

机译:受体特异性嵌合病毒表面多肽,用于靶细胞中病毒和颗粒的掺入和国际化

摘要

Viral and non-viral particles can be incorporated by chimeric viral surfacepolypeptides that are constructed to include a portion of a viral surfacepolypeptide and a portion of a ligand specific for a receptor of the LDL-receptor family. Particles incorporated by the chimeras can target cellsspecific for the receptor type for which the chimera is designed, and can beinternalized in these cells. Exemplary models of the invention includechimeras constructed with a ligand portion of a SERPIN, for example PAI-1, fortargeting cells expressing uPAR bound uPA, and for forming an internalizablecomplex upon contact with LRP cell surface receptor. Accordingly, when theparticle is internalized in the target cell, so is any genome orpolynucleotide encoding a polypeptide for expression that is contained in theviral or non-viral particle. Cell specific gene therapy protocols are therebyaccomplished by the invention.
机译:病毒和非病毒颗粒可通过嵌合病毒表面掺入被构建为包括一部分病毒表面的多肽多肽和对LDL-受体特异的一部分配体受体家族。嵌合体结合的颗粒可以靶向细胞特定于设计嵌合体的受体类型,并且可以是这些细胞内在化。本发明的示例性模型包括用SERPIN的配体部分(例如PAI-1)构建的嵌合体靶向表达uPAR结合uPA的细胞,并形成可内在化的与LRP细胞表面受体接触后形成复合物。因此,当粒子被内化在靶细胞中,任何基因组或编码包含在表达中的多肽的多核苷酸病毒或非病毒颗粒。因此,细胞特异性基因治疗方案由本发明完成。

著录项

  • 公开/公告号CA2240578A1

    专利类型

  • 公开/公告日1997-07-10

    原文格式PDF

  • 申请/专利权人 CHIRON CORPORATION;

    申请/专利号CA19962240578

  • 发明设计人 ROSENBERG STEVEN;

    申请日1996-12-02

  • 分类号C12N15/62;A61K48/00;C07K19/00;C07K14/005;A61K9/127;C12N15/15;C12N15/33;A61K31/70;A61K35/76;C07K14/81;C12N15/86;C12N15/88;

  • 国家 CA

  • 入库时间 2022-08-22 03:23:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号